Design of a phase 3, randomized, double-blind, placebo-controlled, 48-week study to evaluate the efficacy and safety of cendakimab in adult and adolescent patients with eosinophilic esophagitis
| Title: | Design of a phase 3, randomized, double-blind, placebo-controlled, 48-week study to evaluate the efficacy and safety of cendakimab in adult and adolescent patients with eosinophilic esophagitis |
|---|---|
| Authors: | Charriez, Christina M., Zhang, Sandra, de Oliveira, Claudia H.M.C., Patel, Vrunda, Oh, Young S., Hirano, Ikuo, Schoepfer, Alain, Dellon, Evan S. |
| Source: | In Contemporary Clinical Trials December 2024 147 |
| Database: | ScienceDirect |
| ISSN: | 15517144 |
|---|---|
| DOI: | 10.1016/j.cct.2024.107708 |
| Published in: | Contemporary Clinical Trials |
| Language: | English |